Table 2

S. no.Compound nameClinical phaseSponserConditions

(1)Rivaroxaban (BAY59-7939)phase-IIIBayer’s Johnson & Johnson Pharmaceutical Research DevelopmentDeep vein thrombosis (DVT) or Pulmonary embolism (PE)
(2)Radezolidphase-II CompleteRib-X pharmaceuticsUncomplicated skin infection
(3)Torezolidphase-IITrius TherapeuticsComplicated skin and skin-structure infections (cSSSI)
(4)DA-7218phase-IIIDong-A PharmaceuticalAcute bacterial skin and skin-structure infections (ABSSSI)
(5)MRX-1phase-IMicuRx PharmaceuticalBacterial infection
(6)Radezolidphase-IIRib-X pharmaceuticsCommunity-acquired pneumonia
(7)PNU-100480phase- IIaPfizer pharmaceuticalPulmonary Tuberculosis
(8)RX-1741phase- IIRib-X pharmaceuticsInfectious skin disease